Raschi E.; Gatti M.; Gelsomino F.; Ardizzoni A.; Poluzzi E.; De Ponti F., Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, «TARGETED ONCOLOGY», 2020, 15, pp. 449 - 466 [Scientific article]Open Access
Gatti M.; Poluzzi E.; De Ponti F.; Raschi E., Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, «DRUG SAFETY», 2020, 43, pp. 1277 - 1285 [Scientific article]Open Access
Gatti M., Pharmacokinetic analysis investigating gentamicin dosing in a major burned patient complicated by septic shock, «JOURNAL OF CHEMOTHERAPY», 2020, 32, pp. 208 - 212 [Scientific article]
Cento V.; Alteri C.; Mancini V.; Gatti M.; Lepera V.; Mazza E.; Moioli M.C.; Merli M.; Colombo J.; Orcese C.A.; Bielli A.; Torri S.; Gasparini L.E.; Vismara C.; De Gasperi A.; Brioschi P.; Puoti M.; Cairoli R.; Lombardi G.; Perno C.F., Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study, «MYCOSES», 2020, 63, pp. 1299 - 1310 [Scientific article]
Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements, «CLINICAL NUTRITION», 2020, 39, pp. 3854 - 3855 [Comment or similar]
Pujade I.; Perino J.; Mathieu C.; Arnaud M.; Raschi E.; Gatti M.; Bezin J.; Salvo F., Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis, «PHARMACOLOGICAL RESEARCH», 2020, 160, Article number: 105089 , pp. 1 - 9 [Scientific article]
Gatti M.; Raschi E.; Poluzzi E.; Martignani C.; Salvagni S.; Ardizzoni A.; Diemberger I., The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia, «CURRENT HEART FAILURE REPORTS», 2020, 17, pp. 365 - 383 [Scientific article]Open Access
Raschi E.; Bianchin M.; Gatti M.; Squizzato A.; De Ponti F., Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews, «DRUG SAFETY», 2019, 42, pp. 1409 - 1422 [Scientific article]
Gatti M., Feasibility of FreeStyle Libre Flash Glucose Monitoring System in pregnant woman affected by type 1 diabetes, «ACTA DIABETOLOGICA», 2019, 56, pp. 481 - 483 [Scientific article]
Gatti M.; Amato A.M.L.; Bruttomesso D., FreeStyle Libre flash glucose monitoring system in pregnant woman with type 1 diabetes: a focus on accuracy, «ACTA DIABETOLOGICA», 2019, 56, pp. 969 - 970 [Scientific article]
Gatti M.; Gasparini L.E.; Laratta M.; Sigurta A.; Rossi A.; Brioschi P.; Chiara O.; Vismara C.; Scaglione F.; Arlati S., Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment, «EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES», 2019, 38, pp. 1153 - 1162 [Scientific article]
Gatti, M.; Raschi, E.; De Ponti, F., Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study, «BMC PHARMACOLOGY & TOXICOLOGY», 2019, 20, Article number: 65 , pp. 1 - 10 [Scientific article]Open Access
Gatti M.; Gasparini L.E.; Grimaldi C.M.; Abbati D.; Clemente S.; Brioschi P.R.; Fumagalli R.; Scaglione F., Septic shock due to NSTI caused by Actinomyces Turicensis: the role of clinical pharmacology. Case report and review of the literature, «JOURNAL OF CHEMOTHERAPY», 2017, 29, pp. 372 - 375 [Scientific article]
Grisafi D.; Maestro A.; Grumi C.; Piazzoni L.; Tirone G.; Fiore W.; Tessari R.; Gianardi V.; Gatti M.; Tasca F.; Generali D.; Ravelli A.; Lanza F.; Scaglione F., Ibrutinib: from bench side to clinical implications, «MEDICAL ONCOLOGY», 2015, 32, Article number: 225 , pp. 1 - 10 [Scientific article]
